Fever of unknown origin (FUO) is a diagnostic challenge for clinicians. Disorders presenting as fever of unknown origin are varied and extensive. Clinicians often find themselves hopeless with a patient with FUO and try to catch a straw by doing every conceivable test and run therapeutic trials in order to diagnose all of the myriad causes of FUO that are in fact part of the differential diagnosis of FUO in general. The main difficulty with diagnostic testing in patients with FUO is that it is unfocused. All disorders have a specific pattern of organ involvement. In a patient with FUO, there are almost always one or more clues from the history, physical examination, or nonspecific laboratory tests that suggest a particular diagnosis or at least limit diagnostic possibilities. It is worthy to remember that fever of unknown origin is more often caused by an atypical presentation of a common entity than by a rare disorder. Thus a focused diagnostic approach can minimize the miseries of both the clinician & the patient 
Introduction
Clinicians commonly refer to a febrile illness without an initially obvious etiology (sometimes called fever without localizing signs) as fever of unknown origin (FUO). This usage is not accurate. Most febrile illnesses either resolve before a diagnosis can be made or develop distinguishing characteristics that lead to a diagnosis. FUO refers to a prolonged febrile illness without an established etiology despite intensive evaluation and diagnostic testing. The definition of FUO, derived by Petersdorf and Beeson in 1961 from a prospective analysis of 100 cases, has long been the clinical standard 1 . It defines FUO as fever higher than 38.3ºC on several occasions with duration of fever for at least three weeks and uncertain diagnosis after one week of study in the hospital. This definition has been modified over the years to take into account the change in diagnostic modalities and the proportion of patients evaluated for FUO in the ambulatory versus the inpatient setting. Expansion of the definition has also been suggested to include nosocomial, neutropenic, and HIVassociated fevers that may not be prolonged 2 . Thus the new definition by Durack and Street has eliminated the in-hospital evaluation requirements with 3 outpatient visits, or 3 days evaluation in hospital 3 .
The prevalence of FUO in hospitalized patients is reported to be 2.9%. A meta-analysis of 11 studies 4 of FUO indicate that the spectrum of disease includes "no diagnosis" (19%), infections (28%), inflammatory diseases (21%), and malignancies (17%). Deep vein thrombosis (3%) and temporal arteritis in the elderly (16%-17%) were important considerations. True FUOs are uncommon. In 1930s 70% of FUO remained undiagnosed which has become 5-10% in 2000. Undiagnosed FUO patients generally have good outcome. Eighty percent patients recover spontaneously within 4 weeks.
Classification of FUO
FUOs fall into four general categories (Table-I ). The relative frequency of the causes of FUO in each category is the basis for a phased diagnostic approach.
.
Causes of FUO:
In the classic article on FUO by Petersdorf, infectious diseases were the single largest category responsible for FUOs 1 . Years later, Petersdorf again reported on the relative incidences of disorders causing FUOs and found that neoplasms had replaced infections as the most common category causing FUOs 5 . Since the 1990s, there have been further changes in the relative distribution of causes responsible for FUOs 6 . The changes in the relative distribution of entities responsible for FUO are primarily due to changes in diagnostic testing rather than to a major shift in the relative incidence of general categories. The biggest change in diagnostic categories is related to a decrease in the relative proportion of collagen vascular diseases causing FUO. Because of accurate, early diagnostic testing for collagen vascular diseases, those accompanied by fevers of prolonged duration do not remain undiagnosed, and therefore do not fulfill the criteria of an FUO. The collagen vascular diseases that have remained important causes of FUO are those for which no serological tests are available, that is, polymyalgia rheumatica (PMR)/temporal arteritis, late onset rheumatoid arthritis (LORA), and juvenile rheumatoid arthritis (adult Still's disease). 
Evaluation of the Patient with FUO
The main diagnostic difficulty with FUO is a comprehensive, efficient and effective diagnostic approach. Unfortunately, often this has only resulted in excessive diagnostic testing to rule out every disorder causing FUO. An unfocused approach has the effect of incurring unnecessary expense, inconveniencing patients, and delaying or obscuring the FUO diagnostic work-up. The undesirable effect of the ''shotgun approach'' to diagnostic testing is that it under uses the FUO tests appropriate for the most likely diagnostic categories, and it over tests for unlikely diagnoses 8 .
The diagnostic approach to FUOs may be considered as consisting of three phases 9, 10 . The initial phase consists of the initial FUO history and physical examination including confirming the presence of fever & documenting it's pattern, then doing some nonspecific laboratory tests (Table III) . This phase provides the clinician with a general sense of whether the FUO is likely to be caused by an infection or by a rheumatic, inflammatory or neoplastic disorder. After the history, physical exam, and nonspecific laboratory tests, further tests should be based on localizing the disease process anatomically to determine its organ system distribution, which in turn is critical in defining differential diagnostic possibilities.
The second phase involves re-evaluating the patient using a focused FUO history and physical examination and additional nonspecific and specific laboratory tests 12 . The focused FUO evaluation has the effect of narrowing diagnostic possibilities and eliminating possibilities from further diagnostic consideration (Table  IV , V, VI). Among different tests done for FUO, perhaps the most underutilized and undervalued test is serum ferritin levels. Elevations of serum ferritin levels are often ignored or explained away as being due to ferritin acting as an "acute phase reactant." In a patient with FUO, by definition, the process is no longer acute, and elevations in the serum ferritin level take on a very different significance 13 . Elevated serum ferritin levels may suggest certain collagen vascular diseases, for example, systemic lupus erythematosus (SLE), juvenile rheumatoid arthritis (JRA), or temporal arteritis 14, 15 . Ferritin levels may also be elevated in a variety of myeloproliferative disorders as well as with any malignancy. Importantly, elevated ferritin levels in the FUO context strongly argue against an infectious etiology.
During evaluating a patient with FUO, clinicians have to rule out the big and little 3 causes of FUO. The big 3 LGV, lympho-granuloma venereum; RSV, respiratory synaytial Virus; SBE, subacute bacterial endocarditis; SOOT/SGPT, serum glutamiccxaloaoetictransaminase/ serum glutamic pyruvate transaminase; SPEP, serum protein electrophoresis; TA, temporal arteritis; TB, tuberculosis. Here is a proposed algorithm to approach to a patient with FUO 25 .
Abbreviations: (CBC = complete blood count; LFT = liver function test; ESR = erythrocyte sedimentation rate; PPD = purified protein derivative; CT = computed tomography; AFB = acid-fast bacilli; HIV = human immunodeficiency virus; CMV = cytomegalovirus; EBV = Epstein-Barr virus; ASO = antistreptolysin-O antibodies; ANA = antinuclear antibody; TTE = transthoracic echocardiography; TEE = transesophageal echocardiography; MRI = magnetic resonance imaging)
In the third phase the approach has to be more specific and invasive. More specific tests including invasive tests like biopsy or laparoscopy, advanced imaging is required 17, 18 . In this state the question of therapeutic trial comes in which is a controversial issue 19 . Empiric therapy plays a limited role in FUO 20 . Therapeutic trials of antimicrobials or glucocorticoids, while tempting in the effort to "do something," rarely establish a diagnosis. In addition, the diagnostic yield of blood cultures and cultures of biopsy material will be reduced following the initiation of antibiotics 21 . Antimicrobial agents could be expected to suppress, but not cure, an infectious process such as an occult abscess since adjunctive drainage would usually be required. Cunha in 1996 recommended 2 empiric therapy for only 4 situations: antibiotics for culture-negative endocarditis, low-dose corticosteroids for presumed temporal arteritis, antituberculous drugs for suspected military tuberculosis in elderly patients, and naproxen (Naprosyn) for suspected neoplastic fever 22 .
Conclusion
FUOs usually are limited by their progression and are self-terminating or are terminated with effective therapy. Some causes of FUO are prone to recurrence. Using a focused diagnostic approach a three-tiered system leaves very few disorders undiagnosed. Most of the common causes of FUO are diagnosed during the initial FUO evaluation. The focused FUO evaluation should be able to diagnose less common and obscure disorders associated with prolonged and perplexing fevers. It is worthy to remember the saying -"Some fevers remain of unknown origin and represent a source for humility on the part of the diagnostician, but may at the same time serve as an impetus for continued research."
